37 studies found for:    " January 02, 2013":" February 01, 2013"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Recruiting IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
Conditions: HIV Positive;   Malnourished
Intervention: Drug: ZDV+3TC+LPV/r
2 Completed Folinic Acid and Vascular Reactivity in HIV
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Dietary Supplement: Folinic Acid;   Other: Placebo
3 Active, not recruiting Study to Evaluate the Safety and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Versus Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Disoproxil Fumarate in HIV-1 Positive, Antiretroviral Treatment-Naïve Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: E/C/F/TAF;   Drug: E/C/F/TDF;   Drug: Placebo to match E/C/F/TDF;   Drug: Placebo to match E/C/F/TAF
4 Active, not recruiting Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy
Condition: Human Immunodeficiency Virus
Interventions: Drug: Raltegravir;   Drug: Fluconazole;   Drug: Azithromycin;   Drug: Albendazole;   Drug: Isoniazid;   Dietary Supplement: Ready to Use Supplementary Food
5 Active, not recruiting An Expanded Access Protocol for Subjects Who Have Completed Clinical Studies Involving Maraviroc
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Continued Access Arm
6 Active, not recruiting Pulmonary Substudy: A Substudy of Strategic Timing of AntiRetroviral Treatment (START)
Conditions: Chronic Obstructive Pulmonary Disease;   HIV
7 Active, not recruiting Effects of Newly-Initiated QUAD Therapy on Aortic/Coronary Inflammation in ART-Naïve Infected Patients
Condition: HIV
8 Recruiting CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence
Condition: HIV
Intervention: Behavioral: CVCTPLUS
9 Active, not recruiting Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).
Condition: HIV Infection
Intervention: Drug: FTC/TDF (Truvada®)
10 Completed
Has Results
A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults
Conditions: Chronic Hepatitis C;   Human Immunodeficiency Virus
Interventions: Drug: Sofosbuvir;   Drug: RBV
11 Unknown  Mater-Bronx Rapid HIV Testing Project.
Condition: Human Immunodeficiency Virus
Interventions: Other: No participant choice of counselor;   Other: Participant choice of counselor
12 Active, not recruiting An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)
Condition: HIV Infection
Interventions: Behavioral: 3MV;   Behavioral: PCC;   Drug: Emtricitabine/tenofovir (FTC/TDF (Truvada®))
13 Enrolling by invitation The HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial
Condition: Rapid HIV Screening
Interventions: Other: A: Nontargeted rapid HIV screening;   Other: B: Enhanced targeted rapid HIV screening;   Other: C: Traditional targeted rapid HIV screening
14 Recruiting Pediatric HIV Disclosure Intervention
Condition: Paediatric HIV Diagnosis Disclosure
Intervention: Behavioral: Cognitive behavioral intervention to support pediatric HIV disclosure
15 Unknown  Effectiveness of an HIV-adapted IMCI Training and Supervision Programme for Community Health Workers
Conditions: Prevention of Mother-to-child Transmission of HIV;   Antenatal Health Care Utilization;   Postnatal Health Care Utilization;   Infant Feeding Practices
Intervention: Behavioral: Enhanced HIV and MCH training for CHW
16 Recruiting Nutritional and Metabolic Disorders in HIV Infected Children and Adolescent
Condition: HIV-1
17 Recruiting Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy
Condition: HIV
Intervention: Genetic: Autologous CD4+ T cells genetically modified with a retroviral vector expressing the MazF endoribonuclease gene (MazF‐T), given via intravenous infusion.
18 Recruiting The Effect of Antacids and Multivitamins on Raltegravir
Condition: HIV
Interventions: Dietary Supplement: Multivitamins;   Dietary Supplement: Sodium bicarbonate;   Drug: Maalox Plus extra;   Drug: Raltegravir 400 mg
19 Completed Pharmacokinetic Drug Interaction Study Between Raltegravir and Atorvastatin.
Conditions: HIV;   Hypercholesterolaemia
Interventions: Drug: raltegravir;   Drug: Atorvastatin
20 Completed Virological and Immunological Safety of a Dose Reduction Strategy Antiretroviral Regimen With Efavirenz / Tenofovir / Emtricitabine
Condition: HIV
Intervention: Drug: ATRIPLA

   Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results    Last Page
Indicates status has not been verified in more than two years